NO20054898L - Forbindelser med nootropisk virkning, deres fremstilling, farmasoytiske sammensetninger som inneholder disse samt deres anvendelse - Google Patents

Forbindelser med nootropisk virkning, deres fremstilling, farmasoytiske sammensetninger som inneholder disse samt deres anvendelse

Info

Publication number: NO20054898L
Authority: NO; Norway
Prior art keywords: compounds; preparation; pharmaceutical compositions; compositions containing; action
Prior art date: 2003-03-24

Application number

NO20054898A

Other languages

English (en)

Norwegian (no)

Inventor

Carlo Parini

Carlo Farina

Stefania Gagliardi

Marisa Martinelli

Carla Ghelardini

Original Assignee

Nikem Res Srl

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-03-24

Filing date

2005-10-24

Publication date

2005-10-24

2005-10-24 Application filed by Nikem Res Srl filed Critical Nikem Res Srl

2005-10-24 Publication of NO20054898L publication Critical patent/NO20054898L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicinal Preparation (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO20054898A 2003-03-24 2005-10-24 Forbindelser med nootropisk virkning, deres fremstilling, farmasoytiske sammensetninger som inneholder disse samt deres anvendelse NO20054898L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT000573A ITMI20030573A1 (it)	2003-03-24	2003-03-24	Composti ad azione nootropica, loro preparazione,
PCT/EP2004/050339 WO2004085438A2 (en)	2003-03-24	2004-03-22	Pyrroloimidazole derivatives, their preparation, pharmaceutical composition containing them, and their use as nootropic agents

Publications (1)

Publication Number	Publication Date
NO20054898L true NO20054898L (no)	2005-10-24

Family

ID=33042696

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20054898A NO20054898L (no)	2003-03-24	2005-10-24	Forbindelser med nootropisk virkning, deres fremstilling, farmasoytiske sammensetninger som inneholder disse samt deres anvendelse

Country Status (23)

Country	Link
US (3)	US7544705B2 (it)
EP (1)	EP1608655B8 (it)
JP (1)	JP4920408B2 (it)
CN (1)	CN100522963C (it)
AT (1)	ATE401327T1 (it)
AU (1)	AU2004224087B2 (it)
BR (1)	BRPI0408601A (it)
CA (1)	CA2520008C (it)
CY (1)	CY1108401T1 (it)
DE (1)	DE602004015089D1 (it)
DK (1)	DK1608655T3 (it)
EA (1)	EA009558B1 (it)
ES (1)	ES2309534T3 (it)
HR (1)	HRP20050833A2 (it)
IT (1)	ITMI20030573A1 (it)
NO (1)	NO20054898L (it)
NZ (1)	NZ543154A (it)
PL (2)	PL1608655T3 (it)
PT (1)	PT1608655E (it)
RS (1)	RS20050725A (it)
SI (1)	SI1608655T1 (it)
WO (1)	WO2004085438A2 (it)
ZA (1)	ZA200508578B (it)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ITMI20030573A1 (it) *	2003-03-24	2004-09-25	Nikem Research Srl	Composti ad azione nootropica, loro preparazione,
EP1925304A1 (en) *	2006-11-15	2008-05-28	Nikem Research S.R.L.	Pyrrolo[1,2-a]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agents
AU2012201853B2 (en) *	2007-04-16	2013-06-27	Neurotune Ag	Use of dimiracetam in the treatment of chronic pain
ITMI20070770A1 (it) *	2007-04-16	2008-10-17	Brane Discovery S R L	Impiego di dimiracetam nel trattamento del dolore cronico
ES2637497T3 (es)	2008-10-16	2017-10-13	The Johns Hopkins University	Procedimientos y composiciones para la mejora de la función cognitiva
US9125898B2 (en)	2008-11-14	2015-09-08	Neurotune Ag	Acetam derivatives for pain relief
CA2789014C (en) *	2010-02-09	2019-01-15	Michela Gallagher	Methods and compositions for improving cognitive function
JP5919270B2 (ja) *	2010-07-26	2016-05-18	ニューロチューン・アクチエンゲゼルシャフト	ジミラセタムの製造方法
JP6440625B2 (ja)	2012-11-14	2018-12-19	ザ・ジョンズ・ホプキンス・ユニバーシティー	精神分裂病を処置するための方法および組成物
EP3827820A1 (en)	2013-03-15	2021-06-02	The Johns Hopkins University	Brivaracetam for improving cognitive function
US11160785B2 (en)	2013-03-15	2021-11-02	Agenebio Inc.	Methods and compositions for improving cognitive function
HK1251980B (en)	2015-05-22	2020-07-10	Agenebio, Inc.	Extended release pharmaceutical compositions of levetiracetam
JOP20190251A1 (ar)	2017-05-31	2019-10-21	Metys Pharmaceuticals AG	تركيبات تآزرية تشتمل على (r)-ديميراسيتام (1) و(s)-ديميراسيتام (2) بنسبة غير راسيمية
AU2019391309A1 (en)	2018-12-04	2021-05-20	Metys Pharmaceuticals AG	Synergistic compositions comprising (R)-2-(2-oxopyrrolidin-1-yl)butanamide and (S)-2-(2-oxopyrrolidin-1-yl)butanamide in a non-racemic ratio
US20220047587A1 (en)	2018-12-04	2022-02-17	Metys Pharmaceuticals AG	Synergistic compositions comprising r-2-(substituted-sulfonyl)-hexahydro-pyrrolo[1,2-a]pyrazin-6(2h)-ones and s-2-(substituted-sulfonyl)-hexahydro-pyrrolo[1,2-a]pyrazin-6(2h)-ones in a non-racemic ratio

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4582838A (en) *	1984-08-24	1986-04-15	Warner-Lambert Company	Derivatives of dihydro-1H-pyrrolo[1,2-c]imidazol-3,5-dione as cognition activators
US5200406A (en) *	1988-02-08	1993-04-06	I.S.F. Societa Per Azioni	Pharmaceutically useful 2,5-dioxo-1H-octahydroimidazo[1,2-A]azepines
IT1233860B (it) *	1988-02-08	1992-04-21	Isf Spa	Derivati del peridroazacicloalca (1,2-a) imidazolo ad attivita' nootropa
JP3400466B2 (ja) *	1991-10-28	2003-04-28	日本水産株式会社	高純度エイコサペンタエン酸またはそのエステルの製造方法
GB9123641D0 (en) *	1991-11-07	1992-01-02	Isf Spa	Process
ITMI20030573A1 (it) *	2003-03-24	2004-09-25	Nikem Research Srl	Composti ad azione nootropica, loro preparazione,
EP1925304A1 (en) *	2006-11-15	2008-05-28	Nikem Research S.R.L.	Pyrrolo[1,2-a]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agents

2003
- 2003-03-24 IT IT000573A patent/ITMI20030573A1/it unknown
2004
- 2004-03-22 RS YUP-2005/0725A patent/RS20050725A/sr unknown
- 2004-03-22 WO PCT/EP2004/050339 patent/WO2004085438A2/en not_active Ceased
- 2004-03-22 EP EP04741432A patent/EP1608655B8/en not_active Expired - Lifetime
- 2004-03-22 DE DE602004015089T patent/DE602004015089D1/de not_active Expired - Lifetime
- 2004-03-22 EA EA200501501A patent/EA009558B1/ru not_active IP Right Cessation
- 2004-03-22 DK DK04741432T patent/DK1608655T3/da active
- 2004-03-22 CA CA2520008A patent/CA2520008C/en not_active Expired - Fee Related
- 2004-03-22 AT AT04741432T patent/ATE401327T1/de not_active IP Right Cessation
- 2004-03-22 NZ NZ543154A patent/NZ543154A/en unknown
- 2004-03-22 HR HR20050833A patent/HRP20050833A2/hr not_active Application Discontinuation
- 2004-03-22 SI SI200430868T patent/SI1608655T1/sl unknown
- 2004-03-22 PT PT04741432T patent/PT1608655E/pt unknown
- 2004-03-22 US US10/550,483 patent/US7544705B2/en not_active Expired - Fee Related
- 2004-03-22 AU AU2004224087A patent/AU2004224087B2/en not_active Ceased
- 2004-03-22 BR BRPI0408601-5A patent/BRPI0408601A/pt not_active Application Discontinuation
- 2004-03-22 ES ES04741432T patent/ES2309534T3/es not_active Expired - Lifetime
- 2004-03-22 JP JP2006505479A patent/JP4920408B2/ja not_active Expired - Fee Related
- 2004-03-22 PL PL04741432T patent/PL1608655T3/pl unknown
- 2004-03-22 PL PL378939A patent/PL378939A1/pl unknown
- 2004-03-22 CN CNB2004800055916A patent/CN100522963C/zh not_active Expired - Fee Related
2005
- 2005-10-21 ZA ZA200508578A patent/ZA200508578B/en unknown
- 2005-10-24 NO NO20054898A patent/NO20054898L/no not_active Application Discontinuation
2008
- 2008-10-08 CY CY20081101113T patent/CY1108401T1/el unknown
2009
- 2009-02-13 US US12/378,475 patent/US7732473B2/en not_active Expired - Fee Related
2010
- 2010-02-17 US US12/658,973 patent/US20100173945A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20090163565A1 (en)	2009-06-25
CN1756757A (zh)	2006-04-05
US20070027137A1 (en)	2007-02-01
EP1608655B1 (en)	2008-07-16
DK1608655T3 (da)	2008-11-03
RS20050725A (sr)	2007-11-15
WO2004085438A2 (en)	2004-10-07
DE602004015089D1 (de)	2008-08-28
WO2004085438A3 (en)	2004-11-25
JP4920408B2 (ja)	2012-04-18
AU2004224087B2 (en)	2010-04-01
ES2309534T3 (es)	2008-12-16
BRPI0408601A (pt)	2006-03-07
US20100173945A1 (en)	2010-07-08
EP1608655A2 (en)	2005-12-28
CA2520008A1 (en)	2004-10-07
CY1108401T1 (el)	2014-02-12
ATE401327T1 (de)	2008-08-15
EA009558B1 (ru)	2008-02-28
PL378939A1 (pl)	2006-06-12
ITMI20030573A1 (it)	2004-09-25
US7544705B2 (en)	2009-06-09
EA200501501A1 (ru)	2006-04-28
CA2520008C (en)	2011-08-23
HRP20050833A2 (en)	2006-02-28
AU2004224087A1 (en)	2004-10-07
JP2006523198A (ja)	2006-10-12
US7732473B2 (en)	2010-06-08
ZA200508578B (en)	2007-04-25
PL1608655T3 (pl)	2009-03-31
PT1608655E (pt)	2008-10-07
EP1608655B8 (en)	2008-10-15
SI1608655T1 (sl)	2008-12-31
HK1083837A1 (en)	2006-07-14
NZ543154A (en)	2008-03-28
CN100522963C (zh)	2009-08-05

Publication	Publication Date	Title
NO20054898L (no)	2005-10-24	Forbindelser med nootropisk virkning, deres fremstilling, farmasoytiske sammensetninger som inneholder disse samt deres anvendelse
MXPA05005223A (es)	2010-09-07	Diaminotriazoles utiles como inhibidores de proteinas cinasas.
MY139730A (en)	2009-10-30	Cyclic protein tyrosine kinase inhibitors
MXPA05010711A (es)	2005-12-15	Compuestos y composiciones novedosos como inhibidores de proteina-quinasa.
TW200504015A (en)	2005-02-01	Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
DE60327999D1 (de)	2009-07-30	Azolylaminoazine als inhibitoren von proteinkinasen
BRPI0412894A (pt)	2006-10-03	tienopiridina e furopiridina inibidores de quinases
CA2366932A1 (en)	2000-10-26	Cyclic protein tyrosine kinase inhibitors
AU3113902A (en)	2002-07-01	Thiazolyl inhibitors of tec family tyrosine kinases
TW200514776A (en)	2005-05-01	Aminotriazole compounds useful as inhibitors of protein kinases
NO20071915L (no)	2007-05-18	Diaminotriazolforbindelser nyttige som proteinkinaseinhibitorer
BR0312785A (pt)	2005-08-30	Tratamento de desordens relacionadas a tnf(alfa)
MXPA05010496A (es)	2005-11-16	Moduladores alostericos positivos del receptor de acetilcolina nicotinico.
DE60332433D1 (de)	2010-06-17	Azolylaminoazine als proteinkinasehemmer
DE60314603D1 (de)	2007-08-09	Zusammensetzungen brauchbar als protein-kinase- inhibitoren
ATE468336T1 (de)	2010-06-15	Azolylaminoazine als proteinkinasehemmer
ATE464303T1 (de)	2010-04-15	Als inhibitoren von rock und anderen proteinkinasen geeignete zusammensetzungen
MXPA06011327A (es)	2006-12-15	Azaindoles utiles como inhibidores de jak y otras proteinas cinasas.
TR200500221T2 (tr)	2005-03-21	Farmasötik Maddeler Olarak Bisiklik Amino Asitler
NO20076447L (no)	2008-02-08	Bicykliske derivater som modulatorer av ionekanaler
DE602004012578D1 (de)	2008-04-30	Als inhibitoren von c-met geeignete pyrrolzusammensetzungen
ATE457027T1 (de)	2010-02-15	Substituierte 1,4,8-triazaspiroä4.5 decan-2-on- verbindungen zur behandlung von fettsucht
BR112021022380A2 (pt)	2022-03-22	Inibidores de jak
NO20061575L (no)	2006-06-09	Fremgangsmate for fremstilling av renzapride og mellomprodukter derav
WO2006037032A3 (en)	2006-07-20	Prodrugs of protein tyrosine kinase inhibitors

Legal Events

Date	Code	Title	Description
2011-10-24	FC2A	Withdrawal, rejection or dismissal of laid open patent application